At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 63 enrolled
Drug / intervention
BI 443651 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 443651 in Healthy Male Volunteers in a Partially Randomised, Single Blind, Placebo-controlled Trial
In Brief
A Phase 1 clinical trial evaluating BI 443651 and Placebo for Healthy. Completed, enrolled 63 participants across 1 site.
Detailed Summary
To investigate safety, tolerability and pharmacokinetics, following single doses of BI 443651
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2016
Enrollment StartMar 2016
Primary CompletionJun 2016
Study CompletionJun 2016
TodayJul 2026
First PostedMar 11, 2016
Enrollment StartMar 22, 2016
Primary CompletionJun 12, 2016
Study CompletionJun 13, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.3 years ago
Interventions
BI 443651drug
Placebodrug